Preparation method of notoginseng-containing tablet for treating traumatic injury

A technology for bruising and borneol, which is applied in the directions of medical preparations, pharmaceutical formulas, and plant raw materials containing active ingredients, can solve the problems of cumbersome processing procedures and high production costs.

Active Publication Date: 2006-10-04
重庆希尔安药业有限公司
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The purpose of the present invention is to develop a new method for preparing Diedaqili tablets, which overcomes the shortcomings of cumbersome processing procedures and high production costs in the prior art.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] 40.1g of cinnabar, 0.75g of musk, 20g of dried blood, 1.5g of borneol, 10g of notoginseng, 30g of myrrh, 50g of safflower, 40g of frankincense, 85g of angelica, and 42.5g of ten flavors of catechu were used as raw materials; Cinnabar is crushed into 120-mesh ultra-fine powder for later use, musk, dried blood, and borneol are ground into 80-mesh fine powder, and the remaining medicinal materials of Panax notoginseng, myrrh, safflower, frankincense, angelica, and catechu are respectively crushed into 80-mesh fine powder , mix notoginseng, myrrh, safflower, frankincense, angelica, catechin fine powder with the above-mentioned cinnabar fine powder and blood dried blood powder, and musk, blood dried fruit, borneol, notoginseng, myrrh, safflower, Olibanum, angelica, and catechu are all ground into fine powders with a commercially available dust-free pulverizer (TF-450B or TF-350B, produced by Harbin Nano Pharmaceutical Complete Equipment Co., Ltd.), then sieved, made into gran...

Embodiment 2

[0065] The equipment used and its operating method are basically the same as in Example 1, except that 41g of cinnabar, 0.5g of musk, 15g of dried blood, 1.35g of borneol, 35g of notoginseng, 25g of myrrh, 53g of safflower, and 27.5g of frankincense , 65g angelica, 40g catechu and ten flavor medicinal materials are used as raw materials, and the cinnabar is crushed into a 120-mesh ultra-fine powder by the water-flying method. Safflower, frankincense, angelica, and catechu six medicinal materials are respectively crushed into 70-mesh fine powder, and spray-dried at a temperature of 90°C at the inlet air temperature and 45°C at the temperature of the material until the moisture content is 6% (weight percent), and the auxiliary material powder is added Any one of silica gel, low-substituted hydroxypropyl cellulose, starch, dextrin, and magnesium stearate or any four auxiliary materials in any weight ratio, the dosage is 5g.

Embodiment 3

[0067] The equipment used and its operating method are basically the same as in Example 1, except that 45g cinnabar, 0.9g musk, 23g blood dried fruit, 1.25g borneol, 20g Panax notoginseng, 20g myrrh, 41g safflower, 30g frankincense, 90g Angelica sinensis and 50g catechu and Shiwei medicinal materials are used as raw materials, and the cinnabar is crushed into 140 mesh fine powder by water flying method, and the musk, dried blood, and borneol are respectively ground into 80 mesh fine powder, and the rest of Panax notoginseng, myrrh, red Flower, frankincense, angelica, catechu and six medicinal materials are respectively crushed into 80-mesh fine powder, and spray-dried at a temperature of 85° C. of air inlet and 40° C. of material temperature until the moisture content is 6% (percentage by weight), and the auxiliary material microcrystalline Any one of cellulose, carboxymethyl starch sodium, micropowder silica gel, starch, magnesium stearate or three auxiliary materials in any w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of notoginseng-containing tablet for treating traumatic injury, which comprises comminuting cinnabar, musk, dragon's blood resin, baras camphor, notoginseng, myrrh, safflower, frankincense, Chinese angelica root and black catechu, mixing and sieving to obtain granules, drying and charging musk, baras camphor fines, mixing homogenously and tabletting.

Description

technical field [0001] The invention relates to the technical field of manufacturing technology of Chinese patent medicine tablets, in particular to a preparation method of Dieda Qili Tablets for treating bruises. Background technique [0002] Tablets and powders are the drug dosage forms recorded in the Pharmacopoeia, and tablets are a particularly commonly used drug dosage form. The original dosage form of the prior art is: safflower qili powder, which has been included in the national standard compilation of Chinese patent medicines of the State Food and Drug Administration. Although the powder has a quick effect, it is inconvenient to take, the dosage is not accurate, and it cannot meet people's medication needs. The prior art has improved the dosage form of the drug, but because the raw materials must be crushed into fine powder, and in order to achieve high utilization, Production costs and process time are ignored in the prior art. [0003] Chinese patent literature...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/889A61K9/20A61P29/00A61P19/00A61K35/55A61K33/28A61K31/045
Inventor 唐德江陈犁
Owner 重庆希尔安药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap